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Abstract
Erdheim-Chester disease (ECD) is a rare sporadic non-Langerhans cell histiocytic (LCH) proliferative disorder with 
systemic predilection. It usually affects adults in the 5th-7th decades of life and has non-specific clinical manifestations. 
Its suspicion is often heralded by the presence of characteristic radiological findings and subsequently confirmed 
by demonstration of CD68-positive xanthogranulomatous infiltrates on histopathology. Despite being a non-malig-
nant entity, it might be fatal due to organ dysfunction. Imaging plays a key role in the diagnosis, management, and 
follow-up. Imaging findings are essential to establish the diagnosis, assess actual disease burden, and explore the 
aetiopathogenesis and therapeutic options to halt disease progression and associated morbidity.
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Introduction
Erdheim-Chester disease (ECD) is an uncommon non- 
Langerhans cell histiocytic (LCH) proliferative disorder 
with multisystem involvement. Its peak incidence is in 
the 5th-7th decades of life with a slight male predilection, 
although children may occasionally be affected as well. 
Due to the rarity of the condition, its exact aetiopatho-
genesis remains to be established, and no definite genetic 
or infectious basis has been found yet. ECD is postulated 
to be an immune-mediated phenomenon resulting from 
an exaggerated proliferation of helper T cells, leading to 
the release of pro-inflammatory cytokines like interferons 
that results in the recruitment and activation of mast cells 
at the site of involvement [1-3].
Symptomatology of ECD is non-specific and depends 
on the site of involvement. Constitutional symptoms like 
fever, weight loss, night sweats are common, which may 
be mistaken for tuberculosis in the developing countries. 
Overall, skeletal involvement is the commonest, lead-
ing to bone pain as the presenting manifestation in the 
majority of cases. Most common extraosseous manifes-
tations are central diabetes insipidus (DI) and exophthal-
mos; accordingly, a classical clinical triad of ECD includes 
bone pain, central DI, and bilateral exophthalmos.
Clinical, radiological, and light microscopic findings 
may be indistinguishable from LCH. Histopathological-
ly, ECD is characterized by tissue infiltration by lipid- 
laden histiocytes. Demonstration of CD68 positivity in 
such xanthogranulomatous histiocytic infiltrates with 
simultaneous lack of CD1a and Birbeck granules is con-
firmatory, thereby aiding in differentiating ECD from 
LCH.
Like LCH, the sites and extent of extraosseous involve-
ment determine the prognosis in ECD. Although involve-
ment of any organ system will result in its dysfunction, 
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involvement of particular sites like central nervous sys-
tem (CNS) and cardio-vascular system (CVS) certainly 
affects the prognosis due to the observed poor response 
to chemotherapy. Therapeutic advances have definitely 
lowered the morbidity, but the impact on mortality still 
remains dismal with reported 1- and 5-year overall sur-
vival of 96% and 68%, respectively [1,3-6].
Imaging modalities
An array of imaging modalities like radiography, ultra-
sonography (USG), computed tomography (CT), magnet-
ic resonance imaging (MRI), and nuclear imaging may be 
performed depending on the site of involvement. Because 
ECD is a systemic disease with both osseous and extraos-
seous manifestations, imaging is used to ascertain the sites 
of involvement, delineate the extent, and monitor evolu-
tion during follow-up.
Plain radiography and Tc99 bone scintigraphy are 
useful in determining skeletal involvement. For the eval-
uation of thoraco-abdominal and CNS involvement, 
cross-sectional imaging techniques like CT or MRI are 
very useful. Due to its superior contrast resolution, MRI 
is preferred over CT in assessing CVS and CNS involve-
ment. FDG-PET/CT is invaluable for in vivo determina-
tion of disease activity during follow-up. Imaging findings 
along with clinical and demographic characteristics help 
to narrow the differential diagnosis and accordingly guide 
the pathology and immunohistochemistry for confirma-
tion [1,2,5,6].
This review presents the imaging findings in systemic 
involvement of ECD along with site-specific differential 
considerations.
Skeletal system
Skeletal involvement is almost a consistent feature of ECD, 
and is present in nearly 96% of cases. It usually leads to 
bone pain, although the vast majority of bone lesions re-
main clinically silent. There is a predilection for the in-
volvement of appendicular skeleton, especially the long 
bones of the lower extremity. On plain radiographs, there 
is characteristic symmetrical, bilateral cortical sclerosis af-
fecting meta- and/or diaphyses of the long tubular bones 
(Figures 1 and 2). With further progression, there is oblit-
eration of the medulla resulting in obliteration of cortico- 
medullary differentiation. The epiphysis and axial skele-
ton are rarely affected; however, rare case reports suggest 
partial epiphyseal involvement and periostitis. In certain 
cases, the lesions may be either mixed lytic–sclerotic or 
purely lytic, which may be radiologically indistinguisha-
ble from LCH. Concomitant extraosseous involvement is 
frequent, and is seen in nearly half of cases with skeletal 
manifestations.
On Tc99 m scintigraphy, there is an intense, bilaterally 
symmetric uptake at the end of long bones with sparing of 
the epiphysis, which is characteristic of ECD. Not all cases 
may necessarily show uptake on scintigraphy or uptake 
may be seen prior to the appearance of any radiographic 
abnormality. FDG-PET/CT also reveals similar imaging 
Figure 1. Anterior-posterior (AP) radiographs of both forearms and legs showing symmetrical osteosclerosis of the metaphyses and diaphyses of the long 
bones (black arrows)
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findings; however, due to its better spatial resolution than 
Tc99m scintigraphy, it provides an added advantage of ex-
traskeletal evaluation in a single scan.
In patients with osseous lesions, MRI is indicated for 
the assessment of extent of medullary involvement and to 
rule out associated osteonecrosis, which may occur pri-
marily due to the disease or as an adverse effect of chemo-
therapy. Bone involvement on MRI is usually hypointense 
on T1WI and heterogeneously hyperintense on T2WI/
STIR images and shows enhancement [4,5].
Differential diagnoses include other osteosclerotic 
conditions like lymphoma, chronic osteomyelitis, Paget’s 
disease, or metastases; however, amongst these, sym-
metrical metadiaphyseal uptake on nuclear scintigraphy 
is exclusive to ECD. In contrast, there may be symmet-
rical radiotracer uptake in certain storage disorders like 
Niemann-Pick and Gaucher’s disease, but bone lesions in 
these conditions are lytic [4-7].
Central nervous system
CNS involvement is seen in nearly 51% of cases and leads 
to death in nearly one-third of the affected individuals. 
The lesions are usually extra-axial, in contiguity with 
the facial or orbital bones, and may infiltrate the adja-
cent brain parenchyma. Clinical manifestations in CNS 
involvement are paralleled by the nature and location of 
the lesions. Osteosclerosis of calvarial and facial bones is 
a frequent concomitant finding in patients with CNS and 
maxillofacial involvement [2,3,8,9].
Extra-axial
Overall, the commonest neurological manifestation in 
ECD is central DI resulting from the involvement of pos-
terior lobe of the pituitary gland or infundibulum, which 
occurs relatively early in the course of disease. Further, 
diffuse involvement of the pituitary gland may result in 
hypopituitarism. MRI findings depend upon the extent 
of involvement and may vary from the absence of pos-
terior pituitary bright spot on T1WI to the presence of 
enhancing nodules or micronodules in the infundibulum 
and hypothalamus.
Dural and meningeal involvement may be either dif-
fusely infiltrating, or there may be formation of discrete 
masses. These lesions are hypo- to isointense on T1WI. 
Signal characteristics on T2WI are variable; however, T2 
hypointensity, if present, is quite specific for ECD along 
with intense enhancement. Like vascular involvement in 
other conditions, there may be perivascular infiltration 
of the intracranial arteries and veins, which may lead to 
stroke.
Intra-axial
Although rare, intra-axial involvement may be either in 
the form of focal altered signal intensity or space occupy-
ing lesions. Signal alteration in the form of T2-hyperin-
tensity has predilection for the posterior fossa and sym-
metrically involves the dentate and peridentate nucleus of 
the cerebellum without any enhancement. Occasionally, 
there may be involvement of the middle cerebellar pedun-
cle. Owing to the lack of mass effect, these lesions tend to 
remain asymptomatic for long time; however, there may 
be cerebellar and pyramidal syndromes. Similarly, focal 
parenchymal deposits commonly involve the posterior 
fossa but may occur elsewhere as well.
Differential diagnosis: Neuroimaging findings in ECD 
may be indistinguishable from LCH. However, the pattern 
of skull bone involvement in LCH is usually lytic as com-
pared to the osteosclerosis in ECD. Sarcoidosis and men-
ingiomas may also have similar imaging findings. None-
theless, concomitant orbital masses as well as osteosclerotic 
bone involvement is almost exclusive to ECD [1,2,6,8,9].
Orbit
Orbital involvement is frequent in ECD, leading to exo-
phthalmos, which is usually bilaterally symmetrical. Im-
aging is essential to localize the sites of involvement for 
deciding on further management, especially anatomical 
delineation prior to the surgery. CT shows infiltrating, 
hypodense soft tissue usually in retro-orbital, intraconal 
location, encasing the optic nerve and extraocular muscles 
(Figures 3 and 4). Orbital involvement is frequently multi-
compartmental with concomitant involvement of the ex-
traconal, preseptal space, or the lacrimal gland. Although 
bone erosion is not a characteristic feature, osteosclerosis 
of the skull and facial bones may be present. On MRI, the 
soft tissue is isointense on both T1 and T2WI, and lacks 
enhancement [3,6,10,11].
Figure 2. Anterior-posterior radiograph of the pelvis showing patchy osteo-
sclerosis involving the bony pelvis and proximal right femoral shaft (black 
arrows)
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Differential diagnoses for bilateral exophthalmos with 
multicompartmental involvement include Grave’s disease, 
haematological malignancies (leukaemia, lymphoma), 
and sarcoidosis. In Grave’s disease, extraocular muscle 
involvement is the main feature, leading to an increase 
in the muscle volume with sparing of the tendinous in-
sertion. Peripheral blood smear and bone marrow exam-
ination aid in diagnosing haematological malignancies, 
whereas sarcoidosis may be distinguished based on the 
involvement of coats of eyeball and other systemic man-
ifestations. With unilateral involvement, “orbital pseudo-
tumour” is the leading differential diagnosis; however, 
extraocular muscles, including tendons, are primarily 
involved in psuedotumour [1-3,6,8,10,11].
Pulmonary involvement
Lung parenchyma and pleura are affected in about 40–50% 
of cases. Parenchymal involvement may be interstitial, al-
veolar, or combined. Patients tend to remain asymptomat-
ic or may have progressive dyspnoea or cough. The most 
frequent finding on CT is smooth inter- and intralobu-
lar septal thickening; however, a lot of other non-specific 
findings like centrilobular nodules, cysts, consolidation, 
ground glass attenuation, or pleural effusion may also 
be seen. Septal thickening, due to histiocytic infiltration, 
has a lymphangitic distribution involving the peribron-
chovascular bundle, interlobular septa, and visceral pleura 
(Figure 5) [3,5,12].
Pleuroparenchymal involvement on imaging may 
be indistinguishable from other interstitial lung disease 
like LCH, sarcoidosis, pulmonary oedema, or venooc-
clusive disease. In LCH, classical cyst evolution from 
reticulonodular opacities with their bizarre shapes and 
apicobasal gradient favours the diagnosis. In contrast, in 
sarcoidosis, perilymphatic nodules, hilar and mediastinal 
lymphadenopathy are the main imaging findings. Septal 
thickening in cardiogenic pulmonary oedema is usual-
ly smooth, whereas it may be nodular in ECD. Accord-
ingly, imaging findings may be correlated with clinical 
background and other systemic involvement to arrive 
at a definite diagnosis. Interstitial involvement in ECD 
Figure 3. Bilateral proptosis and slowly progressive loss of vision in a 45-year-old male. A) Axial and coronal contrast-enhanced computed tomography 
(CECT) shows infiltrating, heterogeneously enhancing soft tissue in the bilateral retro-orbital, intra- and extraconal retrobulbar spaces (black arrows). 
B) Coronal reformat at the retro-orbital level showing its complete filling with indistinct extraocular muscles and optic nerves. C, D) Bone window shows 
osteosclerosis (white arrow) of the anterior cranial fossa skull base
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Figure 4. A 52-year-old male with axial proptosis in the right eye. Coronal contrast-enhanced computed tomography (CECT) shows (A) infiltrating, 
enhancing soft tissue in the right retro-orbital space (black arrows) encasing the extraocular muscles and optic nerve with contiguous extension through 
the orbital apex into the cavernous sinuses (left > right, curved black arrows). B) Similarly, attenuating soft tissue is also present in both sinonasal cavities 
(white arrows). C) Additionally, there was homogenously enhancing soft tissue in the bilateral masseteric space (right > left, white arrows) with (D) bulky 
submandibular glands and multicompartmental cervical lymphadenopathy (curved white arrow). No secondary bone changes are present
culminates in pulmonary fibrosis, leading to respiratory 
failure [1,3,5,12–15].
Cardiovascular system
Cardiovascular involvement is frequent in ECD and is 
seen in nearly three-fourths of cases. Similar to CNS le-
sions, cardiovascular system (CVS) involvement leads to 
a poor response to chemotherapy and leads to death in 
approximately 60% of cases, secondary to the compromise 
of either chamber filling or cardiac conduction defects 
resulting in myocardial infarction, arrhythmia, or valvu-
lar insufficiency. ECG findings are usually nonspecific, 
resembling any other cardiac conduction abnormalities. 
Although any part of the heart may be affected, the per-
icardium is most commonly involved (Figure 6). Accord-
ingly, the disease process is postulated to stem from the 
subepicardial fat with subsequent myocardium involve-
ment. Like elsewhere, there is soft tissue infiltration of the 
pericardium and/or myocardium. Pericardial involvement 
leads to its thickening and effusion. Myocardial infiltra-
tion more frequently involves the right heart, especially 
the right atrium and atrioventricular groove. On imaging, 
there is plaque-like, infiltrative, smooth thickening of the 
pericardium and/or myocardium that may involve the sep-
tum and valves [3,5,15,16].
Vasculature (aorta and its branches)
The aorta and its branches are the leading sites of ECD in-
volvement, which adversely affects the prognosis. It results 
in plaque-like, perivascular soft tissue encircling the aorta 
A
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Figure 5. A 47-year-old female with Erdheim-Chester disease with skeletal 
involvement. Coronal contrast-enhanced computed tomography (CECT) 
of the chest, performed as part of routine evaluation of systemic involve-
ment, revealed incidental presence of (A, B) bilateral, smooth, interlobular, 
and subpleural septal thickening (white arrows). C) Mild pericardial and 
bilateral pleural effusions (left > right) were also present
A
C
B
Figure 6. Cardiac magnetic resonance imaging of a 43-year-old female with dyspnoea and occasional syncopal episodes. A) Axial, ECG-gated, breath-hold, 
T2-weighted triple IR fast SE image showed mildly T2-hyperintense nodular, infiltrating deposits in the right ventricular free wall (white arrows) and the interatrial 
septum (curved white arrow). B) Axial, gadolinium-enhanced, ECG-gated, breath-hold, T1-weighted double IR fast SE image showed heterogeneous enhance-
ment of the mural and septal thickening (white arrows). Note is made of moderate pericardial effusion and minimal right-sided pleural effusion. C) Coronal 
contrast-enhanced computed tomography (CECT) of the chest of a different patient with multisystem Erdheim-Chester disease involvement revealed enhancing 
soft tissue in the right atrio-ventricular groove encasing the coronary artery (white arrow) and (D) extending further to the root of the great vessels (black arrow)
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Figure 7. A 54-year-old female with abdominal discomfort and bone pain. Contrast-enhanced computed tomography (CECT) of the abdomen shows 
(A) ill-defined, plaque-like, hypodense soft tissue infiltrating the bilateral peri-renal spaces with thickened anterior and posterior renal fascia (white arrow). 
Of note are soft tissue strands extending laterally from the kidneys, i.e., the “hairy kidney sign” (curved white arrows), along with soft tissue in the region 
of renal pelvis causing mild hydronephrosis bilaterally. Also visible was further extension of this soft tissue in the anterior pararenal space, encasing the 
vessels including the aorta but characteristically sparing its posterior space, i.e., the “coated aorta sign” (white line). Laterally, there was bilateral thickening 
of lateroconal fascia with presence of perihepatic soft tissue along the right lobe of the liver (solid arrow). B) Both adrenal glands were also thickened and 
enhancing (white arrow), with surrounding fat stranding; however, there was no adrenal dysfunction. C) Caudally, there was infiltration of the right psoas 
muscle (white arrow). (D) Coronal image showing coated aorta along with perirenal and perihepatic soft tissue thickening
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and its branches. Pathologically, the infiltration is adven-
titial rather than parietal. The pattern of involvement is 
variable and may be segmental with both symmetric and 
asymmetric circumferential forms. Perivascular soft tissue 
thickening may contiguously extend along the ostia of the 
branches of the thoracic and abdominal branches.
It may lead to extrinsic compression of the involved seg-
ment and consequent ischemic complications like cerebro-
vascular events, angina, or mesenteric ischemia depending 
on the site affected. Perivascular infiltration carries a poor 
prognosis as it ultimately resolves with fibrosis with persis-
tence and progression of ischemic manifestations.
On CT, there is hypodense, plaque-like soft tissue cir-
cumferentially involving the aorta and its branches, also 
referred to as the “coated aorta sign”. On MRI, it is isoin-
tense to muscle on both T1 and T2W images with subtle 
enhancement. MRI is advantageous over CT due to better 
assessment of vessel wall [1,3,5,15,16].
Vascular involvement in ECD may be indistinguisha-
ble from other vasculitides, especially Takayasu arteritis. 
However, involvement of vessel wall is only peri-advential 
in ECD as compared to transmural in the latter condition. 
Hence, stenosis, thrombosis, aneurysms, and dilatation 
are more common in Takayasu arteritis. Retroperitoneal 
fibrosis is another leading site-specific differential diag-
nosis, which can be distinguished by lack of characteristic 
skeletal involvement as in ECD [6,15,16].
Kidneys and retroperitoneum
Retroperitoneum including the kidneys is the most com-
mon extraosseous site to be involved, which is seen in ap-
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Table 1. Summary of systemic involvement in Erdheim-Chester disease
System Radiological findings
Skeletal system Bilateral patchy symmetrical cortical and medullary sclerosis with trabecular coarsening involving meta-diaphysis  
of appendicular bones sparing the epiphysis.
Tc99 scintigraphy: symmetric radiotracer uptake at the end of long bones.
Ancillary findings: Bone infarcts. Uncommonly, partial epiphyseal involvement, periostitis.
Central nervous system Extra-axial: More common.
Pituitary gland: Posterior lobe of pituitary, infundibulum.
Dural deposits, dural/pachymengeal thickening, perivascular thickening.
Intra-axial: Abnormal symmetrical T2 hyperintensity with no contrast enhancement or mass effect involving the bilateral 
dentate and peridentate nuclei.
Focal masses commonly in posterior fossa.
Osteosclerosis of the maxillofacial skeleton.
Cardiovascular system Plaque like soft tissue in mediastinum. Infiltration of cardiac chambers (commonly right), pseudo-tumoral soft tissue 
deposits in the atrioventricular sulcus.
Ancillary findings: pericardial thickening, effusion.
Pulmonary Interlobular septal thickening, fissural thickening, centrilobular nodules, ground glass attenuation, consolidation, pleural effusion.
Interstitial pattern more common.
Aorta and its branches Periarortic soft tissue encasing aorta (“coated aorta”) and its branches.
Retroperitoneum Soft tissue in perirenal and pararenal spaces “hairy kidney sign”.
Orbit Retro-orbital intraconal soft tissue usually bilateral leading to exophthalmos. Transcompartmental spread frequent.
proximately 68% of cases. As elsewhere, the majority of 
patients remain asymptomatic or may have non-specific 
clinical manifestations like abdominal pain or dysuria. In 
early stages, large, infiltrating, soft tissue masses are present 
in bilateral perirenal and posterior pararenal spaces, caus-
ing mass effect on the kidney. The retroperitoneal soft tis-
sue deposit is hypoattenuating on CT (Figure 7). On MRI, 
it is isointense to muscle on both T1 and T2W images, with 
mild homogeneous enhancement. Perirenal fat infiltration 
results in spiculated appearance, termed the “hairy kidney 
sign”. As the disease progresses, these soft tissue masses 
compress the pelvicalyceal system or ureters leading to ob-
structive uropathy. Additionally, there may be involvement 
of adrenal glands; however, despite bilateral involvement, 
adrenal insufficiency is rarely encountered [5].
The major differential diagnosis with such pattern of 
involvement is retroperitoneal fibrosis, either primary or 
secondary. In early stages, the pattern of involvement may 
aid in distinction as primary retroperitoneal fibrosis com-
mences proximally from the aortic bifurcation, whereas 
ECD is epicentred at the level of renal hilum. According-
ly, distal ureters are most commonly affected in RPF as 
opposed to the renal pelvis and proximal ureter in ECD. 
Additionally, RPF does not involve the peri-renal space 
and in non–neoplastic causes of RPF there is sparing of 
the retro-aortic space, although compression of IVC may 
be present in both [3–6,15,16].
Unusual sites
ECD may potentially involve any site including skin, breast, 
lymph nodes, thyroid gland, testis, and visceral organs. Skin 
involvement may be plaque-like or nodular, also known as 
xanthomas and xanthelasmas. Involvement of solid visceral 
organs and the mesentery is extremely rare [1,6,15].
Conclusions
ECD is a rare, non-LCH histiocytic proliferative condition 
with systemic predilection that usually affects the elder-
ly. Amongst the myriad of non- specific manifestations, 
precise identification of this entity is essentially a multi-
disciplinary approach based on clinical and demographic 
profile, radiological findings, and final confirmation on 
94histopathology. Despite being a non-neoplastic condi-
tion, its prognosis is dismal and is largely dependent on 
the sites and extent of extraosseous involvement. CNS and 
CVS involvement confers a poor response to chemother-
apy and an inexorable downhill course. Knowledge of its 
imaging findings (Table 1) is essential to avoid misdiagno-
sis, initiate treatment, and determine its exact incidence, 
natural course, and therapeutic guidelines which remain 
to be established due to its rarity.
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